Early and Late Contributions of Glutamate and CGRP to Mechanical Sensitization by Endothelin-1

Alla Khodorova, Judith Richter, Michael Vasko, Gary Strichartz

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Intraplantar injection of endothelin-1 (ET-1) (1.5-10 μM) in the rat produces mechanical allodynia. Here we identify the receptor subtypes for ET-1, glutamate and CGRP critical to such allodynia. Antagonism of ETA or ETB receptors alone, by BQ123 or BQ788, respectively, only partially suppressed allodynia; the combined antagonists prevented allodynia, showing the involvement of both receptor subtypes. Co-injection of NMDA receptor antagonists, (+)MK-801 or D-AP5, with ET-1 also prevented allodynia. In contrast, co-injection of the CGRP1 antagonist CGRP8-37 attenuated only the later phase of allodynia (>30 min). A mechanistic basis for these effects is shown by ET-1's ability to enhance basal release from cultured sensory neurons of glutamate and CGRP (2.4-fold and 5.7-fold, respectively, for 10 nM ET-1). ETA blockade reduced ET-1's enhancement of basal CGRP release by ∼80%, but basal glutamate release by only ∼30%. ET-1 also enhanced the capsaicin-stimulated release of CGRP (up to 2-fold for 0.3 nM ET-1), but did not change capsaicin-stimulated glutamate release. Release stimulated by elevated K+ was not altered by ETA blockade, nor did blockade of ETB reduce any type of release. Thus, ET-1 may induce release of glutamate and CGRP from nerve terminals innervating skin, thereby sensitizing primary afferents, accounting for ET-1-dependent tactile allodynia. Perspective: The endogenous endothelin peptides participate in a remarkable variety of pain-related processes. The present results provide evidence for the participation of ionotropic glutamatergic receptors and CGRP receptors in the hyperalgesic responses to exogenous ET-1 and suggest clinically relevant targets for further study of elevated pain caused by release of endogenous ET-1.

Original languageEnglish
Pages (from-to)740-749
Number of pages10
JournalJournal of Pain
Volume10
Issue number7
DOIs
StatePublished - Jul 2009

Fingerprint

Endothelin-1
Glutamic Acid
Hyperalgesia
Capsaicin
Injections
Calcitonin Gene-Related Peptide Receptors
Endothelin A Receptors
Pain
Aptitude
Dizocilpine Maleate
Endothelins
Sensory Receptor Cells
N-Methyl-D-Aspartate Receptors
Skin
Peptides

Keywords

  • allodynia
  • Endothelin-1
  • mechanical hyperalgesia
  • pain
  • pro-nociception

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Neurology
  • Clinical Neurology

Cite this

Early and Late Contributions of Glutamate and CGRP to Mechanical Sensitization by Endothelin-1. / Khodorova, Alla; Richter, Judith; Vasko, Michael; Strichartz, Gary.

In: Journal of Pain, Vol. 10, No. 7, 07.2009, p. 740-749.

Research output: Contribution to journalArticle

Khodorova, Alla ; Richter, Judith ; Vasko, Michael ; Strichartz, Gary. / Early and Late Contributions of Glutamate and CGRP to Mechanical Sensitization by Endothelin-1. In: Journal of Pain. 2009 ; Vol. 10, No. 7. pp. 740-749.
@article{cb01db797ff54bc896f09f7f7da36fde,
title = "Early and Late Contributions of Glutamate and CGRP to Mechanical Sensitization by Endothelin-1",
abstract = "Intraplantar injection of endothelin-1 (ET-1) (1.5-10 μM) in the rat produces mechanical allodynia. Here we identify the receptor subtypes for ET-1, glutamate and CGRP critical to such allodynia. Antagonism of ETA or ETB receptors alone, by BQ123 or BQ788, respectively, only partially suppressed allodynia; the combined antagonists prevented allodynia, showing the involvement of both receptor subtypes. Co-injection of NMDA receptor antagonists, (+)MK-801 or D-AP5, with ET-1 also prevented allodynia. In contrast, co-injection of the CGRP1 antagonist CGRP8-37 attenuated only the later phase of allodynia (>30 min). A mechanistic basis for these effects is shown by ET-1's ability to enhance basal release from cultured sensory neurons of glutamate and CGRP (2.4-fold and 5.7-fold, respectively, for 10 nM ET-1). ETA blockade reduced ET-1's enhancement of basal CGRP release by ∼80{\%}, but basal glutamate release by only ∼30{\%}. ET-1 also enhanced the capsaicin-stimulated release of CGRP (up to 2-fold for 0.3 nM ET-1), but did not change capsaicin-stimulated glutamate release. Release stimulated by elevated K+ was not altered by ETA blockade, nor did blockade of ETB reduce any type of release. Thus, ET-1 may induce release of glutamate and CGRP from nerve terminals innervating skin, thereby sensitizing primary afferents, accounting for ET-1-dependent tactile allodynia. Perspective: The endogenous endothelin peptides participate in a remarkable variety of pain-related processes. The present results provide evidence for the participation of ionotropic glutamatergic receptors and CGRP receptors in the hyperalgesic responses to exogenous ET-1 and suggest clinically relevant targets for further study of elevated pain caused by release of endogenous ET-1.",
keywords = "allodynia, Endothelin-1, mechanical hyperalgesia, pain, pro-nociception",
author = "Alla Khodorova and Judith Richter and Michael Vasko and Gary Strichartz",
year = "2009",
month = "7",
doi = "10.1016/j.jpain.2009.01.265",
language = "English",
volume = "10",
pages = "740--749",
journal = "Journal of Pain",
issn = "1526-5900",
publisher = "Churchill Livingstone",
number = "7",

}

TY - JOUR

T1 - Early and Late Contributions of Glutamate and CGRP to Mechanical Sensitization by Endothelin-1

AU - Khodorova, Alla

AU - Richter, Judith

AU - Vasko, Michael

AU - Strichartz, Gary

PY - 2009/7

Y1 - 2009/7

N2 - Intraplantar injection of endothelin-1 (ET-1) (1.5-10 μM) in the rat produces mechanical allodynia. Here we identify the receptor subtypes for ET-1, glutamate and CGRP critical to such allodynia. Antagonism of ETA or ETB receptors alone, by BQ123 or BQ788, respectively, only partially suppressed allodynia; the combined antagonists prevented allodynia, showing the involvement of both receptor subtypes. Co-injection of NMDA receptor antagonists, (+)MK-801 or D-AP5, with ET-1 also prevented allodynia. In contrast, co-injection of the CGRP1 antagonist CGRP8-37 attenuated only the later phase of allodynia (>30 min). A mechanistic basis for these effects is shown by ET-1's ability to enhance basal release from cultured sensory neurons of glutamate and CGRP (2.4-fold and 5.7-fold, respectively, for 10 nM ET-1). ETA blockade reduced ET-1's enhancement of basal CGRP release by ∼80%, but basal glutamate release by only ∼30%. ET-1 also enhanced the capsaicin-stimulated release of CGRP (up to 2-fold for 0.3 nM ET-1), but did not change capsaicin-stimulated glutamate release. Release stimulated by elevated K+ was not altered by ETA blockade, nor did blockade of ETB reduce any type of release. Thus, ET-1 may induce release of glutamate and CGRP from nerve terminals innervating skin, thereby sensitizing primary afferents, accounting for ET-1-dependent tactile allodynia. Perspective: The endogenous endothelin peptides participate in a remarkable variety of pain-related processes. The present results provide evidence for the participation of ionotropic glutamatergic receptors and CGRP receptors in the hyperalgesic responses to exogenous ET-1 and suggest clinically relevant targets for further study of elevated pain caused by release of endogenous ET-1.

AB - Intraplantar injection of endothelin-1 (ET-1) (1.5-10 μM) in the rat produces mechanical allodynia. Here we identify the receptor subtypes for ET-1, glutamate and CGRP critical to such allodynia. Antagonism of ETA or ETB receptors alone, by BQ123 or BQ788, respectively, only partially suppressed allodynia; the combined antagonists prevented allodynia, showing the involvement of both receptor subtypes. Co-injection of NMDA receptor antagonists, (+)MK-801 or D-AP5, with ET-1 also prevented allodynia. In contrast, co-injection of the CGRP1 antagonist CGRP8-37 attenuated only the later phase of allodynia (>30 min). A mechanistic basis for these effects is shown by ET-1's ability to enhance basal release from cultured sensory neurons of glutamate and CGRP (2.4-fold and 5.7-fold, respectively, for 10 nM ET-1). ETA blockade reduced ET-1's enhancement of basal CGRP release by ∼80%, but basal glutamate release by only ∼30%. ET-1 also enhanced the capsaicin-stimulated release of CGRP (up to 2-fold for 0.3 nM ET-1), but did not change capsaicin-stimulated glutamate release. Release stimulated by elevated K+ was not altered by ETA blockade, nor did blockade of ETB reduce any type of release. Thus, ET-1 may induce release of glutamate and CGRP from nerve terminals innervating skin, thereby sensitizing primary afferents, accounting for ET-1-dependent tactile allodynia. Perspective: The endogenous endothelin peptides participate in a remarkable variety of pain-related processes. The present results provide evidence for the participation of ionotropic glutamatergic receptors and CGRP receptors in the hyperalgesic responses to exogenous ET-1 and suggest clinically relevant targets for further study of elevated pain caused by release of endogenous ET-1.

KW - allodynia

KW - Endothelin-1

KW - mechanical hyperalgesia

KW - pain

KW - pro-nociception

UR - http://www.scopus.com/inward/record.url?scp=67549084691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67549084691&partnerID=8YFLogxK

U2 - 10.1016/j.jpain.2009.01.265

DO - 10.1016/j.jpain.2009.01.265

M3 - Article

VL - 10

SP - 740

EP - 749

JO - Journal of Pain

JF - Journal of Pain

SN - 1526-5900

IS - 7

ER -